Morgan Stanley Femasys Inc Call Options Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding FEMY
# of Institutions
27Shares Held
1.63MCall Options Held
0Put Options Held
0-
Cm Management, LLC425KShares$403,7500.4% of portfolio
-
Clear Creek Financial Management, LLC307KShares$291,2920.04% of portfolio
-
Geode Capital Management, LLC Boston, MA206KShares$196,1580.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA193KShares$183,0330.0% of portfolio
-
Northern Trust Corp Chicago, IL88.4KShares$83,9990.0% of portfolio
About FEMASYS INC
- Ticker FEMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 11,813,600
- Market Cap $11.2M
- Description
- Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support...